Trident Lifeline has received approval for acquisition of majority stake (51%) in TLL Herbal from the existing shareholders of TLL Herbal, making it Subsidiary of the Company. The objective of acquisition is to expand the business towards new technologies by establishing a Research & Development cum production facility along with integration facility. The Board of Directors, at their meeting held on July 15, 2023, has transacted, approved the same.
Trident Lifeline is engaged in the manufacturing and marketing of quality finished dosages.
